New Study Demonstrates GanedenBC30® Probiotic Limits Reoccurrence…

Findings build on previously published research showing GanedenBC30 alleviated symptoms of C. diff-induced colitis

(PRWeb October 30, 2012)

Read the full story at http://www.prweb.com/releases/2012/10/prweb10070952.htm

Click here for reuse options!
Copyright 2012 Biotechblog

Comments are closed.

%d bloggers like this: